MiR-548b-5p Is Associated with Poor Post-Resection Prognosis and Promotes Tumorigenesis by Targeting ZBTB38 in Hepatocellular Carcinoma
Oncology Research · 2026 · 1-10
DOI: 10.32604/or.2026.089996 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Ju-Chien Jeng und 6 weiteren Autor:innen.
Abstract (Originalsprache)
: Objectives: High recurrence rates of hepatocellular carcinoma (HCC) after curative surgical resection severely limit patient survival, highlighting the need for reliable prognostic biomarkers and therapeutic targets. This study aimed to investigate the clinical significance and oncogenic mechanisms of microRNA-548b-5p (miR-548b-5p) in HCC.
Methods
This retrospective study analyzed paired tumor (T) and adjacent non-tumor (NT) tissue samples from 68 patients with hepatitis B virus-related HCC from a single medical center. Cellular functions and target genes were investigated in HuH-7 and HepG2 cells using RT-qPCR, Western blot, cell malignant phenotype assays, and luciferase reporter assays. In vivo effects were validated using a computer-randomized NOD/SCID xenograft mouse model (n = 6 per group).
Results
An increased miR-548b-5p T/NT ratio independently predicted shorter recurrence-free survival in patients ( p 2.54). Functionally, miR-548b-5p inhibitor significantly reduced cell proliferation ( p < 0.05), anchorage-independent growth ( p < 0.001), migration ( p < 0.01), and invasion ( p < 0.001), which was fully reversed by ZBTB38 silencing ( p < 0.05). Consistently, in vivo tumor growth, Ki-67 expression, and epithelial-to-mesenchymal transition phenotypes were significantly suppressed by the miR-548b-5p inhibitor ( p < 0.001) but effectively restored upon ZBTB38 knockdown ( p < 0.001).
Conclusion
The miR-548b-5p/ZBTB38 signaling axis promotes tumorigenesis, and an elevated tissue miR-548b-5p T/NT ratio serves as an independent prognostic indicator for post-resection HCC recurrence. Targeting this axis represents a promising therapeutic strategy.
Zitieren
APA
Jeng, J., Lin, Y., Wang, J., Shih, F., Li, Y., Li, T., & Teng, C. (2026). MiR-548b-5p Is Associated with Poor Post-Resection Prognosis and Promotes Tumorigenesis by Targeting ZBTB38 in Hepatocellular Carcinoma. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.089996
Vancouver
Jeng J, Lin Y, Wang J, Shih F, Li Y, Li T, et al. MiR-548b-5p Is Associated with Poor Post-Resection Prognosis and Promotes Tumorigenesis by Targeting ZBTB38 in Hepatocellular Carcinoma. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.089996
BibTeX
@article{Jeng2026,
author = {Jeng, Ju-Chien and Lin, Yueh-Te and Wang, John and Shih, Fu-Ying and Li, Yi-Xuan and Li, Tsai-Chung and Teng, Chiao-Fang},
title = {MiR-548b-5p Is Associated with Poor Post-Resection Prognosis and Promotes Tumorigenesis by Targeting ZBTB38 in Hepatocellular Carcinoma},
journal = {Oncology Research},
year = {2026},
volume = {0},
number = {0},
pages = {1--10},
doi = {10.32604/or.2026.089996}
}
EUVIMED